DrugPatentWatch Database Preview
Prinston Inc Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for PRINSTON INC, and what generic and branded alternatives to PRINSTON INC drugs are available?
PRINSTON INC has sixty approved drugs.
There are two tentative approvals on PRINSTON INC drugs.
Summary for Prinston Inc
| US Patents: | 0 |
| Tradenames: | 51 |
| Ingredients: | 51 |
| NDAs: | 60 |
Drugs and US Patents for Prinston Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prinston Inc | ROPINIROLE HYDROCHLORIDE | ropinirole hydrochloride | TABLET;ORAL | 078110-005 | May 5, 2008 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Prinston Inc | RISPERIDONE | risperidone | TABLET;ORAL | 077493-002 | Nov 29, 2011 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Prinston Inc | LISINOPRIL | lisinopril | TABLET;ORAL | 075743-001 | Jul 1, 2002 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Prinston Inc | POTASSIUM CHLORIDE | potassium chloride | CAPSULE, EXTENDED RELEASE;ORAL | 209026-002 | Jun 11, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
